These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 25053972)

  • 1. Invasive cervical cancers from women living in the United States or Botswana: differences in human papillomavirus type distribution.
    Ermel A; Ramogola-Masire D; Zetola N; Tong Y; Qadadri B; Azar MM; Brown DR
    Infect Agent Cancer; 2014; 9():22. PubMed ID: 25053972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Invasive cervical cancers in the United States, Botswana and Kenya: HPV type distribution and health policy implications.
    Ermel A; Qadadri B; Tong Y; Orang'o O; Macharia B; Ramogola-Masire D; Zetola NM; Brown DR
    Infect Agent Cancer; 2016; 11():56. PubMed ID: 27843487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human papillomavirus genotypes in women with invasive cervical cancer with and without human immunodeficiency virus infection in Botswana.
    Tawe L; MacDuffie E; Narasimhamurthy M; Wang Q; Gaseitsiwe S; Moyo S; Kasvosve I; Shin SS; Zetola NM; Paganotti GM; Grover S
    Int J Cancer; 2020 Mar; 146(6):1667-1673. PubMed ID: 31325316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of oncogenic human papillomavirus genotypes in patients diagnosed with anogenital malignancies in Botswana.
    Rantshabeng PS; Moyo S; Moraka NO; Ndlovu A; MacLeod IJ; Gaseitsiwe S; Kasvosve I
    BMC Infect Dis; 2017 Nov; 17(1):731. PubMed ID: 29178840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human papillomavirus genotype distribution and human papillomavirus 16 and human papillomavirus 18 genomic integration in invasive and in situ cervical carcinoma in human immunodeficiency virus-infected women.
    Darwich L; Cañadas MP; Sirera G; Alameda F; Forcada P; Delas J; Fernández I; Llatjós M; Coll J; Clotet B; Videla S
    Int J Gynecol Cancer; 2011 Nov; 21(8):1486-90. PubMed ID: 21892092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subtype distribution of human papillomavirus in HIV-infected women with cervical intraepithelial neoplasia stages 2 and 3 in Botswana.
    Ramogola-Masire D; McGrath CM; Barnhart KT; Friedman HM; Zetola NM
    Int J Gynecol Pathol; 2011 Nov; 30(6):591-6. PubMed ID: 21979597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-risk human papillomavirus prevalence in self-collected cervicovaginal specimens from human immunodeficiency virus (HIV)-negative women and women living with HIV living in Botswana.
    Castle PE; Varallo JE; Bertram MM; Ratshaa B; Kitheka M; Rammipi K
    PLoS One; 2020; 15(2):e0229086. PubMed ID: 32053659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of HPV subtypes in invasive cervical cancer in Botswana patients using a pan-pathogen microarray technology.
    Grover S; Seckar T; Gao L; Bhatia R; Lin X; Zetola N; Ramogola-Masire D; Robertson E
    Tumour Virus Res; 2023 Jun; 15():200262. PubMed ID: 37209888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncogenic viral prevalence in invasive vulvar cancer specimens from human immunodeficiency virus-positive and -negative women in Botswana.
    Tesfalul M; Simbiri K; Wheat CM; Motsepe D; Goldbach H; Armstrong K; Hudson K; Kayembe MK; Robertson E; Kovarik C
    Int J Gynecol Cancer; 2014 May; 24(4):758-65. PubMed ID: 24651632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistence and clearance of high-risk human papillomavirus and cervical dysplasia at 1 year in women living with human immunodeficiency virus: a prospective cohort study.
    Luckett R; Painter H; Hacker MR; Simon B; Seiphetlheng A; Erlinger A; Eakin C; Moyo S; Kyokunda LT; Esselen K; Feldman S; Morroni C; Ramogola-Masire D
    BJOG; 2021 Nov; 128(12):1986-1996. PubMed ID: 34008294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HPV prevalence among young adult women living with and without HIV in Botswana for future HPV vaccine impact monitoring.
    McClung N; Mathoma A; Gargano JW; Nyepetsi NG; Querec TD; Onyekwuluje J; Mine M; Morroni C; Luckett R; Markowitz LE; Ramogola-Masire D
    BMC Infect Dis; 2022 Feb; 22(1):176. PubMed ID: 35193517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unique human papillomavirus-type distribution in South African women with invasive cervical cancer and the effect of human immunodeficiency virus infection.
    van Aardt MC; Dreyer G; Pienaar HF; Karlsen F; Hovland S; Richter KL; Becker P
    Int J Gynecol Cancer; 2015 Jun; 25(5):919-25. PubMed ID: 25950128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HPV genotypes detected in cervical cancers from Alaska Native women, 1980-2007.
    Kelly JJ; Unger ER; Dunne EF; Murphy NJ; Tiesinga J; Koller KR; Swango-Wilson A; Philemonof D; Lounmala X; Markowitz LE; Steinau M; Hennessy T
    Int J Circumpolar Health; 2013; 72():. PubMed ID: 23984281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HPV genotypes in high grade cervical lesions and invasive cervical carcinoma as detected by two commercial DNA assays, North Carolina, 2001-2006.
    Hariri S; Steinau M; Rinas A; Gargano JW; Ludema C; Unger ER; Carter AL; Grant KL; Bamberg M; McDermott JE; Markowitz LE; Brewer NT; Smith JS
    PLoS One; 2012; 7(3):e34044. PubMed ID: 22479516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human papillomavirus prevalence and type distribution in invasive cervical cancer in sub-Saharan Africa.
    Denny L; Adewole I; Anorlu R; Dreyer G; Moodley M; Smith T; Snyman L; Wiredu E; Molijn A; Quint W; Ramakrishnan G; Schmidt J
    Int J Cancer; 2014 Mar; 134(6):1389-98. PubMed ID: 23929250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of human papillomavirus genotypes and associated cervical squamous intraepithelial lesions in HIV-infected women in Botswana.
    Macleod IJ; O'Donnell B; Moyo S; Lockman S; Shapiro RL; Kayembe M; van Widenfelt E; Makhema J; Essex M; Wester C
    J Med Virol; 2011 Oct; 83(10):1689-95. PubMed ID: 21837784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are the human papillomavirus genotypes different in cervical cancer and intraepithelial neoplasia in Jewish Israeli women, a low-risk population?
    Laskov I; Grisaru D; Efrat G; Trejo LL; Grisaru G; Avidor B
    Int J Gynecol Cancer; 2013 May; 23(4):730-4. PubMed ID: 23446379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cervical human papillomavirus genotypes in a high HIV setting: A scoping review of a decade of human papillomavirus epidemiological research in Botswana.
    Tawe L; Ramatlho P; Ketlametswe R; Koobotse M; Robertson ES; Grover S; Ramogola-Masire D; Paganotti GM
    Front Med (Lausanne); 2022; 9():1020760. PubMed ID: 36507502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and genotype-specific distribution of human papillomavirus in Burundi according to HIV status and urban or rural residence and its implications for control.
    Ndizeye Z; Vanden Broeck D; Lebelo RL; Bogers J; Benoy I; Van Geertruyden JP
    PLoS One; 2019; 14(6):e0209303. PubMed ID: 31237894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seroprevalence of HPV vaccine types 6, 11, 16 and 18 in HIV-infected women from South Africa, Brazil and Botswana.
    Firnhaber C; Evans D; Friedman-Khalili R; Willliams S; Michelow P; Matlhagela K; Wester C; Grinsztejn B; Lockman S
    J Clin Virol; 2011 Nov; 52(3):265-8. PubMed ID: 21908233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.